21.00p-1.00 (-4.55%)22 Oct 2021, 17:08
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Open Orphan PLC Fundamentals

Company NameOpen Orphan PLCLast Updated2021-10-22
IndustryBiotechnologySectorHealthcare
Shares in Issue670.855 mMarket Cap£140.88 m
PE Ratio0.06Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0615Debt Equity Ratio0.0239
Asset Equity Ratio1.8967Cash Equity Ratio0.6850
Quick Ratio1.2587Current Ratio1.30
Price To Book Value6.4725ROCE0

Open Orphan PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Open Orphan PLC Company Financials

Assets202020192018
Tangible Assets£5.30 m£1.50 m£901.49
Intangible Assets£6.13 m£2.88 m0
Investments£7.08 m00
Total Fixed Assets£18.50 m£4.38 m£901.49
Stocks£953,000.0000
Debtors£9.81 m£3.62 m£2,704.46
Cash & Equivalents£19.20 m£1.04 m£148,745.37
Other Assets000
Total Assets£48.55 m£9.04 m£182,100.39
Liabilities202020192018
Creditors within 1 year£24.03 m£5.17 m£1.67 m
Creditors after 1 year£2.22 m£1.02 m0
Other Liabilities000
Total Liabilities£26.25 m£6.19 m£1.67 m
Net assets£22.30 m£2.85 m-£1.49 m
Equity202020192018
Called up share capital£668,000.00£254,000.000
Share Premium£44.48 m£15.21 m0
Profit / Loss-£11.16 m-£5.81 m-£4.52 m
Other Equity£22.30 m£2.85 m-£1.49 m
Preference & Minorities000
Total Capital Employed£22.30 m£2.85 m-£1.49 m
Ratios202020192018
Debt Ratio£0.09£0.260
Debt-to-Equity£0.10£0.340
Assets / Equity1.89671.89671.8967
Cash / Equity0.68500.68500.6850
EPS-£0.01-£0.03-£0.03
Cash Flow202020192018
Cash from operating activities£4.17 m-£2.76 m-£996,143.22
Cashflow before financing£17.21 m£370,000.00£24,340.15
Increase in Cash£18.39 m£897,000.00-£69,414.50
Income202020192018
Turnover£20.60 m£3.37 m£12.55 m
Cost of sales£727,000.0000
Gross Profit£19.88 m00
Operating Profit-£10.44 m-£5.13 m-£2.13 m
Pre-Tax profit-£11.16 m-£5.81 m-£4.52 m

Open Orphan PLC Company Background

SectorHealthcare
ActivitiesOpen Orphan PLC is a European-focussed, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.
Latest Interim Date20 Sep 2021
Latest Fiscal Year End Date17 Jun 2021

Open Orphan PLC Directors

AppointedNamePosition
2020-01-20Mr. Michael P Ryan Non-Executive Director,Senior Independent Director
2013-06-18Mr. Adam ReynoldsNon-Executive Director
2014-04-14Mr. Paul Andrew Peter FoulgerExecutive Director,Finance Director and Company Secretary
2016-01-08Mr. David Eric EvansNon-Executive Director,Chairman
2020-07-06Mr. Anthony Francis Richardson Executive Director,Corporate Development Director
2019-06-13Mr. Paul Francis Kennedy Non-Executive Director
2018-12-11Mr. Allan Leigh Wood Executive Director,Chairman
2021-07-14Mr. Cathal Martin FrielExecutive Director,Chairman
2019-06-11Ms. Mary Blake Sheahan Non-Executive Director
2017-08-16Ms. Gracielle Anna Maria Beijerbacht-SchutjensExecutive Director,Chief Operating Officer
2018-03-21Mr. Jonathan David HartshornExecutive Director,Chief Financial Officer
2020-05-04Mr. Mark Robert WarneNon-Executive Director
2017-04-06Mr. Kees GroenExecutive Director
2020-01-20Dr. Christian Bernard MillaExecutive Director,Chief Operating Officer
2021-07-14Professor Brendan BuckleyNon-Executive Director
2020-01-20Dr. Maurice Treacy Executive Director

Open Orphan PLC Contact Details

Company NameOpen Orphan PLC
Address1 Berkeley Street, London, W1J 8DJ
Telephone+353 15373269
Websitehttps://www.openorphan.com

Open Orphan PLC Advisors

Nominated AdviserCenkos Securities
Phone+44 2073978900
StockbrokerCenkos Securities
Phone+44 2073978900
StockbrokerHybridan LLP
Phone+44 203764 2341
Fax+44 2076001586
BankUlster Bank Group
AuditorJeffreys Henry LLP
Phone+44 2073092222
Fax+44 2073092309
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
RegistrarS.L.C Registrars Ltd
Phone+44 1903706150
SolicitorBPE Solicitors LLP
Phone+44 1242224433
Fax+44 1242574285